Stay updated on Reslizumab in EGPA: Clinical Trial

Sign up to get notified when there's something new on the Reslizumab in EGPA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reslizumab in EGPA: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The label for locating contact information was updated from 'Find Contact Information' to 'Find contact information', and the page revision was updated from v3.6.6 to v3.7.0, indicating a small update to the page metadata.
    Difference
    0.1%
    Check dated 2026-09-15T23:43:36.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The revision label changed from v3.6.5 to v3.6.6, indicating a new version of the page template. This appears to be an internal update rather than a substantive change to page content.
    Difference
    0.1%
    Check dated 2026-09-01T19:33:52.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, indicating a minor site update that does not change the study details shown on the page.
    Difference
    0.1%
    Check dated 2026-08-11T18:25:17.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a new page/version release. No visible study content changes are described in the provided data.
    Difference
    0.1%
    Check dated 2026-07-28T11:31:20.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.3, signaling a new page build. This update reflects a platform or asset patch rather than changes to the study data or presentation of the trial details.
    Difference
    0.1%
    Check dated 2026-06-30T01:24:42.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    New navigation and guidance links were added to help users check eligibility, locate contact information, read the study record, and learn how to join the study. A formatting tweak to the Intervention/Treatment header and a revision tag update from v3.5.5 to v3.6.0 were applied.
    Difference
    0.5%
    Check dated 2026-06-15T18:47:54.000Z thumbnail image

Stay in the know with updates to Reslizumab in EGPA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reslizumab in EGPA: Clinical Trial page.